Vertex Pharmaceuticals Inc
NASDAQ: VRTX
$466.36
-$11.54 (-2.4%)
Real Time Data Delayed 15 Min.
VRTX Articles
These are five of the best stocks in a sector that has been humming along in what has been a turbulent year. They are all included on the Goldman Sachs Conviction List too.
Published:
Thursday's top analyst upgrades and downgrades included Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify and Tesla.
Published:
Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero Energy and Walt Disney.
Published:
Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies is a proverbial one-trick pony, and they all are potential takeover...
Published:
Companies like IBM, Amazon, Western Digital and EA all posted big moves, some far more than what was expected, in Thursday's after-hours trading session for January 30, 2020.
Published:
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
Published:
Monday's top analyst upgrades, downgrades and initiations included Adobe, Amgen, Bank of America, Broadcom, CME, Goldman Sachs, Micron Technology, PepsiCo, UnitedHealth, Urban Outfitters and Vertex...
Published:
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Published:
Tuesday's the top analyst upgrades, downgrades and initiations included Dropbox, Electronic Arts, Halliburton, Intuit, Juniper Networks, ProLogis, Silicon Motion, Taiwan Semiconductor, Textron and...
Published:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap, Snap and Twitter.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Published:
These four stocks make good sense now, as they all have outstanding upside potential and are among the Jefferies top U.S. growth calls for this week.
Published:
Last Updated:
On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.
Published:
Last Updated:
Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross, plus two that went the other way.
Published:
Last Updated: